Compare RAVE & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAVE | MYO |
|---|---|---|
| Founded | 1958 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 44.8M |
| IPO Year | 1995 | 2017 |
| Metric | RAVE | MYO |
|---|---|---|
| Price | $3.16 | $0.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 41.3K | ★ 405.2K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | $15,120,000.00 | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $9.10 |
| Revenue Next Year | N/A | $13.59 |
| P/E Ratio | $20.87 | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $2.25 | $0.61 |
| 52 Week High | $3.75 | $2.06 |
| Indicator | RAVE | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 45.95 |
| Support Level | $3.07 | $0.99 |
| Resistance Level | $3.48 | $1.13 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 25.30 | 40.28 |
Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.